ThaiPR.NET https://www.thaipr.net/location/mumbai-india-and-vancouver-bc Press Release Distribution Center of Thailand Thu, 30 Apr 2026 18:05:11 +0700 hourly 1 https://wordpress.org/?v=6.1.1 <![CDATA[Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize’s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal]]> https://www.thaipr.net/en/health_en/3212915 Thu, 14 Jul 2022 12:42:17 +0700 health_en https://www.thaipr.net/en/health_en/3212915 Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) – peer reviewed, high impact journal published the successful phase 3 clinical trial results of SaNOtize’s Nitric Oxide Nasal Spray (NONS) study titled: ‘SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal […]

The post Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize’s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal appeared first on ThaiPR.NET.

]]> <![CDATA[Glenmark and SaNOtize announce positive Results from Phase 3 Clinical Trial of NONS (FabiSpray®) in Non-Hospitalized Adult Indian Patients with COVID-19]]> https://www.thaipr.net/en/health_en/3155082 Thu, 10 Feb 2022 16:38:00 +0700 health_en https://www.thaipr.net/en/health_en/3155082 Phase 3 trial in India met the key endpoints and demonstrated reduction of viral load of 94% in 24 hours and 99% in 48 hours. NONS was safe and well tolerated in COVID-19 patients. Glenmark received manufacturing and marketing approval from India’s drug regulator for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval […]

The post Glenmark and SaNOtize announce positive Results from Phase 3 Clinical Trial of NONS (FabiSpray®) in Non-Hospitalized Adult Indian Patients with COVID-19 appeared first on ThaiPR.NET.

]]>